A Study of Tadalafil in Benign Prostatic Hyperplasia

Phase 1 Completed 24 enrolled Eli Lilly and Company

Parallel-groupOpen-labelBasic science

Summary

The purpose of this study is to investigate the pharmacokinetics of tadalafil in Japanese and non-Japanese men with Benign Prostatic Hyperplasia (BPH). The safety of tadalafil will also be studied.

Timeline

Start: 2010-07
Primary completion: 2011-04
Completion: 2011-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tadalafil	Small molecule	5 mg	Oral

A Study of Tadalafil in Benign Prostatic Hyperplasia

Summary

Timeline

Drugs

Indications